High-grade gliomas (HGG) are aggressive central nervous system tumors with poor outcomes; in fact, only a small subset of patients survive beyond 5 years.
ESMO Open published a clinical update in Oncology on 17 Mar 2026.
The item focuses on Molecular immune signature identifies microglia and NK cell infiltration as a favorable prognostic marker in adult-type high-grade glioma.
Review the original article for the full source wording and details.